Chronic hypertension in pregnancy
Chronic HTN · Obstetric
Physician-written · Verified by three sets of doctors · Reviewed November 2026
Bedside summary
Hypertension present before pregnancy or before 20 weeks requires tighter control, switching to pregnancy-safe agents, and heightened surveillance for superimposed pre-eclampsia and fetal growth restriction.
Red flags
- BP 160/110 or higher
- New or worsening proteinuria
- Symptoms of severe pre-eclampsia
- Fetal growth restriction or abnormal Dopplers
- Signs of placental abruption
Assessment
Differential diagnosis
- Gestational hypertension
- Superimposed pre-eclampsia
- White-coat hypertension
- Secondary hypertension (renal, endocrine)
- Masked hypertension
Investigations
- Baseline urine protein:creatinine ratio and renal function
- FBC, liver function and urate
- ECG and assessment for end-organ damage if long-standing
- Serial BP monitoring and home BP where appropriate
- PlGF-based testing if superimposed pre-eclampsia suspected
- Serial growth and liquor ultrasound with umbilical artery Doppler
Management
- Confirm diagnosis and review current antihypertensives
- Stop ACE inhibitors, ARBs and thiazide diuretics because of fetal risk and switch to pregnancy-safe agents
- Aim to keep BP at or below 135/85 mmHg
- Start aspirin 150 mg at night from 12 weeks for superimposed pre-eclampsia prophylaxis
- Monitor BP and urinalysis at increased frequency through pregnancy
- Arrange serial growth scans from 28 weeks (or earlier if indicated)
- Watch for superimposed pre-eclampsia with symptom review and bloods
- Plan timing and mode of birth; offer birth by 37-39 weeks depending on control and complications
- Continue antihypertensives postnatally, reviewing and converting to standard agents compatible with breastfeeding
Drugs & doses
Labetalol 100-200 mg PO twice daily, titrated (avoid in asthma)
Nifedipine modified-release 20-30 mg PO once to twice daily
Methyldopa 250 mg PO two to three times daily (avoid if history of depression)
Enalapril or captopril postnatally if needed (breastfeeding-compatible)
Disposition
Obstetric-led care with maternal medicine input; admit for BP 160/110 or more, suspected superimposed pre-eclampsia, or fetal compromise.
Complications & pitfalls
- Superimposed pre-eclampsia (up to a quarter of women)
- Fetal growth restriction
- Placental abruption
- Preterm birth
- Maternal cardiovascular and renal injury
Exam pearls
- Target 135/85 does not increase small-for-gestational-age risk and reduces severe hypertension
- Avoid treating below 110/70 to preserve placental perfusion
- ACE inhibitors are contraindicated but captopril and enalapril are acceptable postnatally
- A rising urate or falling platelets suggests superimposed pre-eclampsia
Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.